Responsive Neurostimulation for Epilepsy in Children

Status: draft · Last updated 2026-11-02 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • Closed loop: RNS detects and treats, and its recordings help refine localization. Benefit builds over years .
  • Children: about 75% median reduction and about 10% seizure-free in pooled data. Lesional and directly targeted cases do better .
  • Neocortical: put strips or depth leads at the onset zone. Closer is better early . Eloquent and motor cortex can be treated safely .
  • Mesial temporal: depth leads. Bilateral foci are fine, and outcome doesn't depend on exact hippocampal position .
  • Thalamic (CM): for multifocal or generalized epilepsy. About 60% respond, with sensorimotor side effects that bipolar or low-frequency stimulation can fix .
  • Young children: check skull thickness on CT, fit the device to the skull contour, and consider a larger craniectomy for growth. Watch for infection .

Landmark papers

  • Pivotal RNS trial (Morrell et al., Neurology 2011): randomized sham-controlled trial in 191 adults. Seizures fell 37.9% with responsive stimulation vs 17.3% with sham, with no mood or cognitive worsening .

Responsive neurostimulation (RNS) is a closed-loop system. A cranially mounted neurostimulator records electrocorticography from 2 leads, detects seizure patterns and delivers brief stimulation. It is FDA-approved for adults with 1 or 2 seizure foci and is used off-label in children . There are two broad strategies:

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:rns_layout:37ca05ea093c445e© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Coronal view: RNS neurostimulator seated in a parietal skull ferrule, a subdural strip lead over a neocortical focus, and a depth lead with contacts in the centromedian thalamusneurostimulator inparietal ferruledepth lead,contacts in CMsubdural strip over a neocortical focusthalamusscalpskullduracortexcoronal view, viewer’s left = patient’s right; not to scale
Schematic coronal view: the neurostimulator sits in a parietal craniectomy (ferrule). One lead is a subdural strip over a neocortical focus, and the other is a depth lead with contacts in the centromedian thalamus. Not to scale.

Adult evidence that underpins pediatric use

Evidence in children

Neocortical and mesial temporal targeting

Thalamic targeting (RNS)

How CM-RNS leads are placed and programmed (pediatric series)

Device placement in young children

Related topics

References

  1. Morrell MJ; RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 2011;77(13):1295–1304. doi:10.1212/WNL.0b013e3182302056. PMID 21917777. verified
  2. Panov F, Ganaha S, Haskell J, et al. Safety of responsive neurostimulation in pediatric patients with medically refractory epilepsy. J Neurosurg Pediatr 2020;26(5):525–532. doi:10.3171/2020.5.PEDS20118. PMID 33861559. verified
  3. Nair DR, Laxer KD, Weber PB, et al. Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology 2020;95(9):e1244–e1256. doi:10.1212/WNL.0000000000010154. PMID 32690786. verified
  4. Eliashiv D, Rao VR, Jobst BC, et al. Postapproval study for brain-responsive neurostimulation for drug-resistant focal epilepsy: three-year efficacy and interim safety results. Neurology 2026;106(9):e214875. doi:10.1212/WNL.0000000000214875. PMID 42030518. verified
  5. Levy AS, Bystrom LL, Brown EC, et al. Responsive neurostimulation for treatment of pediatric refractory epilepsy: a pooled analysis of the literature. Clin Neurol Neurosurg 2023;234:108012. doi:10.1016/j.clineuro.2023.108012. PMID 37839147. verified
  6. Rosenberg A, Wang R, Petchpradub M, et al. Responsive neurostimulation in pediatric epilepsy: a systematic review and individual patient meta-analysis supplemented by a single institution case series in 105 aggregated patients. Childs Nerv Syst 2024;40(11):3709–3720. doi:10.1007/s00381-024-06546-x. PMID 39060746. verified
  7. Nagahama Y, Zervos TM, Murata KK, et al. Real-world preliminary experience with responsive neurostimulation in pediatric epilepsy: a multicenter retrospective observational study. Neurosurgery 2021;89(6):997–1004. doi:10.1093/neuros/nyab343. PMID 34528103. Full text (PMC) verified
  8. Jobst BC, Kapur R, Barkley GL, et al. Brain-responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas. Epilepsia 2017;58(6):1005–1014. doi:10.1111/epi.13739. PMID 28387951. verified
  9. Geller EB, Skarpaas TL, Gross RE, et al. Brain-responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy. Epilepsia 2017;58(6):994–1004. doi:10.1111/epi.13740. PMID 28398014. verified
  10. Sadeghzadeh S, Purger DA, Bhanot P, et al. sEEG-guided responsive neurostimulation to treat neocortical epilepsy: a multicenter retrospective study of the efficacy and safety of depth electrode-mediated neuromodulation. Epilepsia Open 2026;11(1):146–161. doi:10.1002/epi4.70180. PMID 41251192. Full text (PMC) verified
  11. Jung BC, Ho V, Quraishi I, et al. Responsive neurostimulation targeting the primary motor cortex for treatment of drug-resistant epilepsy. Seizure 2026;137:27–31. doi:10.1016/j.seizure.2026.02.024. PMID 41780246. verified
  12. Enner S, El-Hallal M, Hogan K, et al. Safety & feasibility of responsive neurostimulation in children with refractory epilepsy: a single-center experience. Seizure 2024;114:121–124. doi:10.1016/j.seizure.2023.12.005. PMID 38141494. verified
  13. Mohanty D, Houck KM, Trandafir C, et al. Responsive neurostimulation of thalamic nuclei for regional and multifocal drug-resistant epilepsy in children and young adults. J Neurosurg Pediatr 2024;34(1):40–48. doi:10.3171/2024.2.PEDS23531. PMID 38608307. verified
  14. Bystrom LL, Levy AS, Brown EC, et al. Thalamic responsive neurostimulation for the treatment of refractory epilepsy: an individual patient data meta-analysis. J Neurosurg Pediatr 2023;32(3):366–375. doi:10.3171/2023.5.PEDS22559. PMID 37347644. verified
  15. Ahn S, Edmonds B, Rajaraman RR, et al. Bilateral centromedian nucleus of thalamus responsive neurostimulation for pediatric-onset drug-resistant epilepsy. Epilepsia 2024;65(8):e131–e140. doi:10.1111/epi.18031. PMID 38845459. Full text (PMC) verified
  16. Nanda P, Sisterson N, Walton A, et al. Centromedian region thalamic responsive neurostimulation mitigates idiopathic generalized and multifocal epilepsy with focal to bilateral tonic-clonic seizures. Epilepsia 2024;65(9):2626–2640. doi:10.1111/epi.18070. PMID 39052021. verified
  17. Kwon CS, Schupper AJ, Fields MC, et al. Centromedian thalamic responsive neurostimulation for Lennox-Gastaut epilepsy and autism. Ann Clin Transl Neurol 2020;7(10):2035–2040. doi:10.1002/acn3.51173. PMID 32860345. verified
  18. Nistal D, Edmonds B, Barrios-Anderson A, et al. Thalamic neuromodulation for pediatric drug-resistant epilepsy: a case series evaluating deep brain stimulation and responsive neurostimulation. J Neurosurg Pediatr 2026;38(4):456–464. doi:10.3171/2026.3.PEDS25489. PMID 42537226. verified

Verification (2026-11-02): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. The pediatric skull-growth, skull-thickness and device-placement points come from the full text of reference 7, and the CM-RNS planning and programming details from the full text of reference 15, both on PMC. References 1, 3, 4, 8–11, 14 and 16 are adult or mixed-age. The statements that strips cover surface foci and depth leads reach deep foci, and that leads are placed at the SEEG-defined onset zone, are standard practice summarized from references 8–10. Two-canister (two-device) placement is from reference 12. The schematic is an original figure.